BioROSA Technologies
Latest round
- Seed
Last raised
- Jun 2018
Total raised
- Undisclosed
Investors
- 1
About BioROSA Technologies
BioROSA Technologies Inc.Founded in 2018 in Belmont, US, BioROSA Technologies Inc. focuses on diagnostic solutions for Autism Spectrum Disorder.BioROSA Technologies specializes in the development of a broad-spectrum blood test designed to detect Autism Spectrum Disorder (ASD) in children as young as 18 months. The core product uses a simple blood draw to analyze specific biomarkers that are indicative of ASD, utilizing advanced computer algorithms to generate a risk score. This innovative testing solution aims to facilitate early intervention services, which are crucial for improving language, social skills, and cognitive development in affected children. BioROSA primarily targets healthcare providers, including pediatricians and specialists in developmental disorders, who serve parents and caregivers concerned about the developmental health of their children.BioROSA Technologies has established a revenue model centered around the sale of its flagship blood test for ASD detection. The company engages in direct-to-consumer transactions as well as partnerships with healthcare providers, creating a structured framework for delivering its services to end users. Clients, such as hospitals and pediatric clinics, may order the test and subsequently provide results to parents, who play a key role in the decision-making process regarding potential early intervention strategies. The pricing structure for the BioROSA test is designed to ensure accessibility for institutions, allowing for broader adoption of the technology within the healthcare community.45 mn from July 2019 to enhance product development and market penetration. The company is focused on expanding its offerings in the ASD diagnostic space and aims to enter new geographic markets beyond the United States. Specific plans for upcoming products and geographic expansions are currently under development, with the company aiming for a broader reach by 2023.
Who invested in BioROSA Technologies
1 investor across 1 round
See all investors in BioROSA Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 14, 2018
Amount
Undisclosed
Investors
Questions about BioROSA Technologies
Who invested in BioROSA Technologies?
BioROSA Technologies has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioROSA Technologies raised?
BioROSA Technologies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BioROSA Technologies last raise money?
BioROSA Technologies's most recent round on record is a Seed, in Jun 2018.
What does BioROSA Technologies do?
BioROSA Technologies is a biotechnology company.
Where is BioROSA Technologies headquartered?
BioROSA Technologies is headquartered in Belmont, US.
Which VCs invest in companies like BioROSA Technologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at BioROSA Technologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like BioROSA Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.